Northern Virginia Oncology Group- Site Number : 8400045

Fairfax, Virginia 22031

1 studies enrolling now · 1 studies all time

What they study most

Plasma Cell Myeloma Refractory

Studies at this site

• A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma — Recruiting now